Work

Camrelizumab combined with liposomal doxorubicin and dacarbazine as first-line therapy for advanced, recurrent, and metastatic undifferentiated pleomorphic sarcoma: A phase II study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.11513

Authors: Tian Gao, Jiayong Liu, Zhichao Tan, Chujie Bai, Yunfei Shi, Shu Li, Lu Zhang, Xinyu Wang, Zhiwei Fang, Xueyi Tan, Rong Xi, Tao Deng, Ruifeng Xue, Zhengfu Fan

Institution: Peking University Cancer Hospital

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162491435

Cites:

Cited by:

Related to: